M

Maccura Biotechnology Co Ltd
SZSE:300463

Watchlist Manager
Maccura Biotechnology Co Ltd
SZSE:300463
Watchlist
Price: 14.02 CNY 0.29% Market Closed
Market Cap: 8.6B CNY
Have any thoughts about
Maccura Biotechnology Co Ltd?
Write Note

Gross Margin
Maccura Biotechnology Co Ltd

56%
Current
55%
Average
43.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
56%
=
Gross Profit
1.6B
/
Revenue
2.8B

Gross Margin Across Competitors

Country CN
Market Cap 8.6B CNY
Gross Margin
56%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 209.8B USD
Gross Margin
41%
Country US
Market Cap 178.5B USD
Gross Margin
60%
Country KR
Market Cap 71.2T KRW
Gross Margin
50%
Country CH
Market Cap 38.5B CHF
Gross Margin
29%
Country US
Market Cap 37.5B USD
Gross Margin
35%
Country US
Market Cap 37.6B USD
Gross Margin
55%
Country US
Market Cap 27.5B USD
Gross Margin
59%
Country US
Market Cap 22.4B USD
Gross Margin
35%
Country US
Market Cap 23.1B USD
Gross Margin
62%

Profitability Report

View the profitability report to see the full profitability analysis for Maccura Biotechnology Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
56%
=
Gross Profit
1.6B
/
Revenue
2.8B
What is the Gross Margin of Maccura Biotechnology Co Ltd?

Based on Maccura Biotechnology Co Ltd's most recent financial statements, the company has Gross Margin of 56%.